{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:54:26Z","timestamp":1787586866109,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010998","name":"Indian Society of Organ Transplantation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010998","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ekir.2023.09.034","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T04:17:05Z","timestamp":1696393025000},"page":"2557-2568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Clinical Practice Patterns in IgA Nephropathy: A Global Questionnaire-Based Survey"],"prefix":"10.1016","volume":"8","author":[{"given":"Bhavik","family":"Bansal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amritesh","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boon Wee","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhivanan","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunkumar","family":"Subbiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipankar","family":"Bhowmik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay Kumar","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hern\u00e1n","family":"Trimarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumita","family":"Bagchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2023.09.034_bib1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2215\/CJN.07420716","article-title":"IgA nephropathy","volume":"12","author":"Rodrigues","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.09.034_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00281-021-00884-7","article-title":"Is IgA nephropathy the same disease in different parts of the world?","volume":"43","author":"Zhang","year":"2021","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.ekir.2023.09.034_bib3","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.34067\/KID.0002972021","article-title":"The phenotypic difference of IgA nephropathy and its race\/gender-dependent molecular mechanisms","volume":"2","author":"Suzuki","year":"2021","journal-title":"Kidney360"},{"key":"10.1016\/j.ekir.2023.09.034_bib4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2023.09.034_bib5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s10157-003-0255-x","article-title":"Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy","volume":"7","author":"Yagi","year":"2003","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.ekir.2023.09.034_bib6","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/0886022X.2015.1128251","article-title":"The efficacy of tonsillectomy on clinical remission and relapse in patients with IgA nephropathy: a randomized controlled trial","volume":"38","author":"Yang","year":"2016","journal-title":"Ren Fail"},{"key":"10.1016\/j.ekir.2023.09.034_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.ajkd.2019.01.026","article-title":"Effects of hydroxychloroquine on proteinuria in IgA nephropathy: a randomized controlled trial","volume":"74","author":"Liu","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2023.09.034_bib8","first-page":"CD003962","article-title":"Non-immunosuppressive treatment for IgA nephropathy","volume":"3","author":"Reid","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ekir.2023.09.034_bib10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12882-016-0337-0","article-title":"Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis","volume":"17","author":"Currie","year":"2016","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2023.09.034_bib11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10157-019-01700-1","article-title":"New strategies and perspectives on managing IgA nephropathy","volume":"23","author":"Selvaskandan","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.ekir.2023.09.034_bib12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5414\/CN107244","article-title":"\u03c9-3 fatty acids therapy for IgA nephropathy: a meta-analysis of randomized controlled trials","volume":"77","author":"Liu","year":"2012","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.ekir.2023.09.034_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.kint.2021.03.033","article-title":"DAPA-CKD trial committees and investigators. A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy","volume":"100","author":"Wheeler","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2023.09.034_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"Herrington","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2023.09.034_bib15","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","article-title":"Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group","volume":"91","author":"Trimarchi","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2023.09.034_bib16","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/ckj\/sfab244","article-title":"Corticosteroids and mycophenolic acid analogues in immunoglobulin A nephropathy with progressive decline in kidney function","volume":"15","author":"Huerta","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2023.09.034_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.54054","article-title":"Effectiveness of mycophenolate mofetil among patients with progressive IgA nephropathy: a randomized clinical trial","volume":"6","author":"Hou","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ekir.2023.09.034_bib18","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1056\/NEJMoa1415463","article-title":"STOP-IgAN investigators. Intensive supportive care plus immunosuppression in IgA nephropathy","volume":"373","author":"Rauen","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2023.09.034_bib19","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1001\/jama.2022.5368","article-title":"Effect of oral methylprednisolone on decline in kidney function or kidney failure in patients with IgA nephropathy: the TESTING randomized clinical trial","volume":"327","author":"Lv","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2023.09.034_bib20","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1053\/j.ajkd.2015.06.013","article-title":"Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathy","volume":"66","author":"Hogg","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2023.09.034_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12939-018-0748-6","article-title":"Barriers for conducting clinical trials in developing countries- a systematic review","volume":"17","author":"Alemayehu","year":"2018","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.ekir.2023.09.034_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ekir.2021.11.012","article-title":"Three-year clinical outcomes of the first South Asian prospective longitudinal observational IgA nephropathy cohort","volume":"7","author":"Alexander","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2023.09.034_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev-biodatasci-102920-112550","article-title":"African global representation in biomedical sciences","volume":"4","author":"Mulder","year":"2021","journal-title":"Annu Rev Biomed Data Sci"},{"key":"10.1016\/j.ekir.2023.09.034_bib24","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.34067\/KID.0000000000000165","article-title":"Global incidence of IgA nephropathy by race and ethnicity: a systematic review","volume":"360","author":"Kiryluk","year":"2023","journal-title":"Kidney360"},{"key":"10.1016\/j.ekir.2023.09.034_bib25","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/MNH.0000000000000902","article-title":"Novel agents for treating IgA nephropathy","volume":"32","author":"Kunter","year":"2023","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ekir.2023.09.034_bib26","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.ekir.2022.05.022","article-title":"International physicians Delphi survey: managing patients with IgA nephropathy","volume":"7","author":"Floege","year":"2022","journal-title":"Kidney Int Rep"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024923015279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024923015279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:46:50Z","timestamp":1762832810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024923015279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2468024923015279"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2023.09.034","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Practice Patterns in IgA Nephropathy: A Global Questionnaire-Based Survey","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2023.09.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}